Gyeonggi-do, South Korea

Sang Chul Park

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 7(Granted Patents)


Location History:

  • Seochogu, Seoul, KR (1999)
  • Gyeong-Gi Do, KR (2009 - 2023)

Company Filing History:


Years Active: 1999-2023

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: **Sang Chul Park: Pioneering Innovations in Vaccine Development**

Introduction

Sang Chul Park is a prominent inventor based in Gyeonggi-do, South Korea. With a remarkable portfolio of seven patents, his work primarily focuses on vaccine development, particularly in the fields of neurodegenerative diseases and infectious virus vaccines. His innovative contributions have the potential to significantly impact public health.

Latest Patents

One of Sang Chul Park's latest patents is centered around the preparation of a flagellin vaccine adjuvant-based vaccine. This invention represents a significant advancement in vaccine technology, aiming to induce the production of antibodies that recognize the conformation of antigens. The vaccine composition he developed is designed for use in treating neurodegenerative diseases and in creating infectious virus vaccines. This composition not only promotes the production of highly specific antibodies but also holds promise for ameliorating, preventing, or treating various diseases.

Career Highlights

Throughout his career, Sang Chul Park has made significant contributions to the field of biomedical research. His tenure at Samsung Electronics Co., Ltd. has provided him with valuable experience in research and development, enhancing his capabilities as an inventor. His patents are a testament to his innovative spirit and dedication to advancing medical science.

Collaborations

Sang Chul Park has collaborated with several notable professionals, including Hee Jung Kim and Myoung Soo Shin. These collaborations have played a crucial role in refining his research and bringing innovative solutions to the forefront of vaccine technology.

Conclusion

Sang Chul Park's dedication to innovation in vaccine development highlights the importance of inventive minds in tackling pressing health challenges. With seven patents under his name and ongoing research efforts, he continues to inspire future generations of inventors and researchers in the field of biomedical science. His contributions are pivotal in shaping the future of vaccines and disease prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…